Publicaciones en las que colabora con Francisco Javier Beaumont Ezcurra (26)

2021

  1. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

2020

  1. Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

    Nefrologia, Vol. 40, Núm. 3, pp. 223-236

2019

  1. The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

    Cardiovascular Research, Vol. 115, Núm. 4, pp. 696-698

2018

  1. Myocardial remodeling in hypertension toward a new view of hypertensive heart disease

    Hypertension, Vol. 72, Núm. 3, pp. 549-558

2017

  1. Hypertensive Heart Disease

    Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526

  2. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

    Scientific Reports, Vol. 7

  3. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

    Journal of Hypertension, Vol. 35, Núm. 4, pp. 853-861

  4. The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

    Medical Clinics of North America, Vol. 101, Núm. 1, pp. 43-52

2016

  1. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure

    Journal of the American College of Cardiology, Vol. 67, Núm. 3, pp. 251-260

  2. Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients

    Clinical Science, Vol. 130, Núm. 23, pp. 2139-2149

2015

  1. Circulating biomarkers of myocardial fibrosis: The need for a reappraisal

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2449-2456

2013

  1. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

2011

  1. Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure

    Journal of Hypertension, Vol. 29, Núm. 5, pp. 876-883

  2. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia

    Cardiovascular Research, Vol. 92, Núm. 2, pp. 247-255

2001

  1. Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 2-5

  2. Marcadores bioquímicos de fibrosis miocárdica en las enfermedades cardíacas

    Hipertensión y Riesgo Vascular, Vol. 18, Núm. 8, pp. 383-388

  3. Oxidative stress in arterial hypertension role of NAD(P)H oxidase

    Hypertension

  4. Polymorphisms and promoter overactivity of the p22phox gene in vascular smooth muscle cells from spontaneously hypertensive rats

    Circulation Research, Vol. 88, Núm. 2, pp. 217-222

  5. Vascular oxidative stress and endothelial dysfunction

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 1, pp. 61-66

2000

  1. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats

    Hypertension, Vol. 35, Núm. 5, pp. 1055-1061